Evidence Based Medicine
Each intervention is graded by evidence level, effect size, reproducibility, safety profile, and relevance to long-horizon clinical outcomes.
MISSION
Stop Ageing Organ by Organ.
Our central goal is to build the London institute where dedicated teams for each organ system work strictly through evidence-based and comprehensive medicine, with AI and data science at the supercharged core of decision-making.
Each clinical team is accountable for a specific organ system and operates to one standard: evidence first, comprehensive assessment, measurable outcomes, and continuous protocol refinement.
Our model integrates internal medicine, preventive cardiology, endocrinology, neurology, immunology, and lifestyle medicine so that organ-focused teams can work with shared data and coordinated decision-making.
AI and data science power the operating layer: multimodal data integration, longitudinal risk modelling, protocol optimisation, and continuous outcome learning across all organ-system teams.
We continue appointing an international faculty of physician-researchers and raising capital for a dedicated London headquarters. All work is governed by a formal ethics charter, and privately patented advances must include defined public-benefit access pathways.
CLINICAL FRAMEWORK
From hypothesis to patient benefit, every decision must be evidence-graded, system-aware, and biologically coherent.
Comprehensive Medicine
We model interacting systems, not isolated markers: cardiometabolic, neurocognitive, endocrine, inflammatory, renal, and behavioural domains are managed as one map.
First Principles
Where evidence is emerging, we reason from validated physiology and pathophysiology, then test assumptions against longitudinal clinical data.
INSTITUTIONAL PARTNERSHIPS | PHYSICIAN FACULTY | RESEARCH CAPITAL
contact [at] newumg.com
For strategic partnerships, physician-research appointments, and long-term capital collaboration.
Email New UMG